ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer
November 26, 2018OBI Pharma, Inc., a Taiwan, China biopharma company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for.... -
OBI Pharma granted FDA ODD for OBI-888
November 26, 2018OBI Pharma, Inc., a Taiwan, China biopharma company, has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for OBI-888 for the treatment of Pancreatic Cancer
Pharma Sources Insight January 2025
